about
Pharmacogenetics and psychopharmacotherapy.Desipramine, substrate for CYP2D6 activity: population pharmacokinetic model and design elements of drug-drug interaction trialsDetermination of debrisoquine metabolic ratio from hourly urine collections in healthy volunteers.Debrisoquine oxidation in a Finnish population: the effect of oral contraceptives on the metabolic ratio.Genetic polymorphism of sparteine/debrisoquine oxidation: a reappraisal.Interethnic variability of CYP2D6 alleles and of predicted and measured metabolic phenotypes across world populations.Cytochrome P-450-dependent hydroxylation in migraine.
P2860
Q33962212-1F8D85D9-BED7-4F9F-92A3-2C8F7C242A1AQ34180464-0CC505CB-1FAF-4281-8FA9-514BACAFC81AQ34417415-CBC36360-4936-4AB8-8577-060A950130BDQ34418240-AD56F434-FEB9-4BBC-AC73-7E19C391CBA9Q37782957-88D8D5B9-2443-4C43-AC71-A19FFD7FF307Q38260323-DBBC503D-4F12-42AF-8DB3-37AC421081DCQ41126681-526F3B47-279C-4E43-AB3B-DE0AEE8DE0E3
P2860
description
1986 nî lūn-bûn
@nan
1986 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1986 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1986年の論文
@ja
1986年論文
@yue
1986年論文
@zh-hant
1986年論文
@zh-hk
1986年論文
@zh-mo
1986年論文
@zh-tw
1986年论文
@wuu
name
Debrisoquine oxidation in an Australian population.
@ast
Debrisoquine oxidation in an Australian population.
@en
Debrisoquine oxidation in an Australian population.
@nl
type
label
Debrisoquine oxidation in an Australian population.
@ast
Debrisoquine oxidation in an Australian population.
@en
Debrisoquine oxidation in an Australian population.
@nl
prefLabel
Debrisoquine oxidation in an Australian population.
@ast
Debrisoquine oxidation in an Australian population.
@en
Debrisoquine oxidation in an Australian population.
@nl
P2093
P2860
P1476
Debrisoquine oxidation in an Australian population.
@en
P2093
P2860
P304
P356
10.1111/J.1365-2125.1986.TB02827.X
P407
P577
1986-05-01T00:00:00Z